Novasep expands East Asia presence
Novasep (Pompey, France) has announced the opening of a new facility in Shanghai, China. This new site will complement Novasep?s existing 12 global synthesis and process sites in France, the US, Germany, Belgium and the Bahamas.
Novasep (Pompey, France) has announced the opening of a new facility in Shanghai, China. This new site will complement Novasep’s existing 12 global synthesis and process sites in France, the US, Germany, Belgium and the Bahamas.
Almost half of the new 2000 m2 building will be dedicated to innovation and process development through new laboratory, piloting and FAT testing areas.
The company has faced continued growth in demand in East Asia for its design and supply of purification technologies and integrated processes in batch and continuous membrane filtration, ion exchange and chromatography. The increased innovation capabilities at the new site means that Novasep should be able to meet the demand and expand output.
Antoine Baule, president of Novasep Process, commented, “Novasep has ensured that its supply capabilities can satisfy ever increasing demands in China and East Asia.”
Jean de Lataillade, general manager of Novasep Asia, added, “With food and feed industry ingredient volumes rising above 100,000 tons per year in some Chinese productions, this requires more cost effective and environmentally friendly processes, and strong engineering capabilities. The Shanghai site will further enable Novasep to compete globally in both low volume pharma markets, as well as large volume industrial biotech markets.”
For more information please visit ref="http://www.novasep.com">www.novasep.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
